Metropolis Healthcare Limited
NSE:METROPOLIS.NS
2135.4 (INR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,133.551 | 3,310 | 2,911.171 | 3,085.006 | 2,770.911 | 2,825.459 | 2,854.564 | 3,003.493 | 2,798.586 | 3,058.85 | 2,930.526 | 3,026.196 | 3,267.641 | 2,915.336 | 2,747.77 | 2,883.505 | 1,431.284 | 2,064.174 | 2,228.538 | 2,232.808 | 2,032.963 | 2,007.499 | 1,904.353 | 1,931.045 | 1,757.657 |
| Cost of Revenue
| 1,630.433 | 1,712.339 | 593.39 | 640.758 | 593.798 | 598.427 | 657.889 | 700.099 | 641.934 | 772.498 | 650.018 | 703.433 | 749.206 | 744.368 | 702.601 | 753.665 | 401.475 | 560.148 | 535.555 | 542.04 | 497.263 | 463.83 | 438.574 | 458.001 | 426.231 |
| Gross Profit
| 1,503.118 | 1,597.661 | 2,317.781 | 2,444.248 | 2,177.113 | 2,227.032 | 2,196.675 | 2,303.394 | 2,156.652 | 2,286.352 | 2,280.508 | 2,322.763 | 2,518.435 | 2,170.968 | 2,045.169 | 2,129.84 | 1,029.809 | 1,504.026 | 1,692.983 | 1,690.768 | 1,535.7 | 1,543.669 | 1,465.779 | 1,473.044 | 1,331.426 |
| Gross Profit Ratio
| 0.48 | 0.483 | 0.796 | 0.792 | 0.786 | 0.788 | 0.77 | 0.767 | 0.771 | 0.747 | 0.778 | 0.768 | 0.771 | 0.745 | 0.744 | 0.739 | 0.72 | 0.729 | 0.76 | 0.757 | 0.755 | 0.769 | 0.77 | 0.763 | 0.758 |
| Reseach & Development Expenses
| 0 | 62.565 | 20.9 | 28.099 | 24.204 | 25.092 | 18.929 | 16.027 | 27.397 | 34.454 | 19.749 | 14.885 | 19.991 | 29.981 | 9.202 | 9.171 | 19.954 | 37.986 | 12.319 | 15.21 | 15.409 | 22.247 | 12.315 | 12.345 | 13.8 |
| General & Administrative Expenses
| 0 | 734.303 | 0 | 0 | 0 | 619.469 | 0 | 0 | 0 | 715.698 | 0 | 0 | 0 | 593.057 | 0 | 0 | 0 | 1,002.153 | 0 | 0 | 0 | 69.261 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 327.738 | 0 | 0 | 0 | 261.555 | 0 | 0 | 0 | 260.322 | 0 | 0 | 0 | 131.251 | 0 | 0 | 0 | 112.628 | 0 | 0 | 0 | 29.093 | 0 | 0 | 0 |
| SG&A
| 970.402 | 1,062.041 | 974.259 | 998.597 | 897.144 | 881.024 | 846.064 | 896.739 | 849.626 | 976.02 | 902.245 | 900.891 | 915.266 | 724.308 | 529.324 | 485.59 | 460.744 | 1,114.781 | 484.133 | 495.798 | 472.426 | 98.354 | 446.281 | 476.4 | 414.527 |
| Other Expenses
| 24.578 | 25.394 | 23.061 | 12.19 | 30.525 | 12.263 | 66.243 | 43.351 | 30.389 | -115.111 | 26.102 | 55.728 | 37.635 | -79.706 | 37.414 | 30.847 | 31.54 | -44.946 | 21.895 | 19.674 | 15.467 | 0.318 | 22.235 | 0 | 20.536 |
| Operating Expenses
| 970.402 | 1,062.041 | 1,919.219 | 1,918.534 | 1,755.932 | 1,758.517 | 1,722.069 | 1,728.895 | 1,683.469 | 1,601.141 | 1,696.063 | 1,570.747 | 1,627.788 | 1,284.404 | 1,288.433 | 1,331.376 | 1,007.505 | 1,229.001 | 1,162.931 | 1,157.375 | 1,068.209 | 1,000.211 | 1,026.646 | 995.801 | 933.279 |
| Operating Income
| 532.716 | 535.62 | 421.623 | 537.904 | 451.706 | 480.778 | 540.849 | 617.85 | 473.183 | 568.578 | 584.445 | 752.016 | 1,050.647 | 886.564 | 756.736 | 798.464 | 22.304 | 275.025 | 530.052 | 533.393 | 467.491 | 543.458 | 439.133 | 430.441 | 398.147 |
| Operating Income Ratio
| 0.17 | 0.162 | 0.145 | 0.174 | 0.163 | 0.17 | 0.189 | 0.206 | 0.169 | 0.186 | 0.199 | 0.249 | 0.322 | 0.304 | 0.275 | 0.277 | 0.016 | 0.133 | 0.238 | 0.239 | 0.23 | 0.271 | 0.231 | 0.223 | 0.227 |
| Total Other Income Expenses Net
| -21.944 | -30.3 | -53.074 | -56.784 | -59.806 | -61.745 | -61.1 | -69.885 | -44.896 | -3.906 | -23.521 | 25.056 | -19.804 | -70.032 | 20.928 | 15.433 | 12.833 | -41.147 | -2.064 | -1.329 | -74.091 | -24.19 | 15.986 | 45.803 | 16.752 |
| Income Before Tax
| 510.772 | 505.32 | 368.549 | 481.12 | 391.9 | 419.033 | 479.749 | 547.965 | 428.287 | 564.672 | 560.924 | 777.072 | 1,030.843 | 816.532 | 777.664 | 813.897 | 35.137 | 233.878 | 527.988 | 532.064 | 393.4 | 519.268 | 455.119 | 476.244 | 414.899 |
| Income Before Tax Ratio
| 0.163 | 0.153 | 0.127 | 0.156 | 0.141 | 0.148 | 0.168 | 0.182 | 0.153 | 0.185 | 0.191 | 0.257 | 0.315 | 0.28 | 0.283 | 0.282 | 0.025 | 0.113 | 0.237 | 0.238 | 0.194 | 0.259 | 0.239 | 0.247 | 0.236 |
| Income Tax Expense
| 129.669 | 140.06 | 95.658 | 124.52 | 102.095 | 84.144 | 121.102 | 143.202 | 92.646 | 163.188 | 148.739 | 193.097 | 281.626 | 203.338 | 191.312 | 208.744 | 6.35 | 78.944 | 107.85 | 100.761 | 124.254 | 170.85 | 141.831 | 176.143 | 140.504 |
| Net Income
| 379.473 | 364.069 | 271.584 | 354.549 | 287.96 | 333.553 | 357.987 | 403.313 | 333.974 | 399.867 | 410.388 | 582.665 | 748.9 | 613.464 | 585.694 | 602.788 | 29.005 | 154.929 | 420.722 | 429.805 | 267.8 | 344.889 | 312.036 | 304.837 | 239.746 |
| Net Income Ratio
| 0.121 | 0.11 | 0.093 | 0.115 | 0.104 | 0.118 | 0.125 | 0.134 | 0.119 | 0.131 | 0.14 | 0.193 | 0.229 | 0.21 | 0.213 | 0.209 | 0.02 | 0.075 | 0.189 | 0.192 | 0.132 | 0.172 | 0.164 | 0.158 | 0.136 |
| EPS
| 7.41 | 7.11 | 5.3 | 6.92 | 5.62 | 6.51 | 6.99 | 7.88 | 6.53 | 7.82 | 8.02 | 11.39 | 14.65 | 12.05 | 11.5 | 11.88 | 0.57 | 3.05 | 8.38 | 8.57 | 5.34 | 6.8 | 6.26 | 6.1 | 4.83 |
| EPS Diluted
| 7.37 | 7.08 | 5.28 | 6.9 | 5.61 | 6.49 | 6.97 | 7.85 | 6.49 | 7.78 | 7.98 | 11.34 | 14.58 | 12.05 | 11.46 | 11.8 | 0.57 | 3.05 | 8.37 | 8.55 | 5.33 | 6.8 | 6.25 | 6.1 | 4.8 |
| EBITDA
| 788.133 | 799.793 | 671.529 | 760.298 | 659.911 | 715.124 | 771.126 | 833.651 | 715.304 | 801.536 | 779.394 | 958.164 | 1,061.35 | 980.128 | 903.851 | 939.451 | 152.621 | 365.088 | 657.537 | 644.053 | 562.413 | 582.923 | 509.988 | 476.982 | 461.596 |
| EBITDA Ratio
| 0.252 | 0.242 | 0.231 | 0.246 | 0.238 | 0.253 | 0.27 | 0.278 | 0.256 | 0.262 | 0.266 | 0.317 | 0.325 | 0.336 | 0.329 | 0.326 | 0.107 | 0.177 | 0.295 | 0.288 | 0.277 | 0.29 | 0.268 | 0.247 | 0.263 |